Page last updated: 2024-10-21

4,5,6,7-tetrahydroisoxazolo(4,5-c)pyridin-3-ol and Epilepsy, Absence

4,5,6,7-tetrahydroisoxazolo(4,5-c)pyridin-3-ol has been researched along with Epilepsy, Absence in 1 studies

4,5,6,7-tetrahydroisoxazolo(4,5-c)pyridin-3-ol: inhibitor of GABA uptake systems; RN given refers to parent cpd

Epilepsy, Absence: A seizure disorder usually occurring in childhood characterized by rhythmic electrical brain discharges of generalized onset. Clinical features include a sudden cessation of ongoing activity usually without loss of postural tone. Rhythmic blinking of the eyelids or lip smacking frequently accompanies the SEIZURES. The usual duration is 5-10 seconds, and multiple episodes may occur daily. Juvenile absence epilepsy is characterized by the juvenile onset of absence seizures and an increased incidence of myoclonus and tonic-clonic seizures. (Menkes, Textbook of Child Neurology, 5th ed, p736)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Vergnes, M1
Marescaux, C1
Micheletti, G1
Depaulis, A1
Rumbach, L1
Warter, JM1

Other Studies

1 other study available for 4,5,6,7-tetrahydroisoxazolo(4,5-c)pyridin-3-ol and Epilepsy, Absence

ArticleYear
Enhancement of spike and wave discharges by GABAmimetic drugs in rats with spontaneous petit-mal-like epilepsy.
    Neuroscience letters, 1984, Jan-27, Volume: 44, Issue:1

    Topics: Action Potentials; Aminocaproates; Animals; Baclofen; Epilepsy, Absence; gamma-Aminobutyric Acid; Is

1984